NICE (UK) positive for Kimmtrak (tebentafusp) for treating advanced uveal melanoma – Immunocore Ltd
NICE (UK): 1.1 Tebentafusp is recommended, within its marketing authorisation, for treating HLA‑A*02:01-positive unresectable or metastatic uveal melanoma in adults. Tebentafusp is only recommended if the company provides… read more.
